Healthcare to All. Co. Ltd.
MSc. Health Economics, University of York
European Market Access University Diploma, Université Claude Bernard Lyon 1
Emiko started her career as a registered clinical nurse in both the UK and Japan, specialised in neurosurgery and intensive care management.
After gaining MSc. Health Economics, she has been involved in various local, regional and global level projects in healthcare policy, market access and health economics evidence development. Her clients include but are not limited to pharmaceutical and medical device companies, medical professional associations and government.
Business partner in heor
A successful HEOR analysis that is accepted by HTA organization and peer reviewed journal is developed based on professional knowledge and business experience. H2A Co. Ltd. has 100% collaboration in Japanese HEOR evidence development with Vista Health Pte. Ltd., a Singapore based HEOR specialist consultancy company since January 2019.
Joe’s background and experience spans industry and consulting roles across multiple continents. He worked as a Principal at IMS Health, subsequently moving to Singapore in 2012 to set up and manage the Real-World Evidence and HEOR team for the Asia-Pacific region, before setting up a HEOR consultancy company, Vista Health Pte. Ltd..
Joe currently holds the position of Associate Director for ESSEC Business School Institute of Health Economics and Management Asia-Pacific.
business partner in market access
Healthcare market is changing rapidly, therefore a market access project requires knowledge and experience in international market as well as in-depth local knowledge and connections to key stakeholders. H2A Co. Ltd. has local and global business partners to conduct market access project.
Anthony specializes in healthcare consulting in market access, growth strategy & portfolio management with 100+ client assignments covering Asia Pacific & Emerging Markets spanning 9 years. Previously, he was Senior Principal for IMS Consulting Group’s Asia Pacific Singapore office. His over 20 years of life science experience includes but not limited to at GSK & IMS Health advising multinational & local pharma, consumer health, med tech, providers, health ministries, NGOs & financial firms in Asia, EMEA & LatAm.
Bruno is a former Executive Officer and Head of Market Access at Bayer Yakuhin, Ltd., and former head of the Medical Economic Evaluation Committee of EFPIA-Japan.
After graduating from ESCP, a business school in Paris, and with a MA in Japanese, over the last 30 years, Bruno worked in government and in industry, mostly in Japan and in Singapore.
Since 2016, he operates as an independent consultant, assisting pharmaceutical and devices companies on data generation, market access, patient relations and, more generally business development, across several therapeutic indications.